Literature DB >> 33606171

The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.

Liqi Liu1, Zi Li1, Jianfang Zhou1, Jian Lu1, Xiyan Li1, Jia Liu1, Ning Xiao1, Dayan Wang2.   

Abstract

Influenza vaccines represent the most effective preventive strategy to control influenza virus infections; however, adaptive mutations frequently occur in the hemagglutinin (HA) glycoprotein during the preparation of candidate vaccine virus and production of vaccine in embryonated eggs. In our previous study, we constructed candidate vaccine virus (HA-R) to match the highly pathogenic avian influenza H7N9 viruses A/Guangdong/17SF003/2016 as part of a pandemic preparedness program. However, mixed amino acids (R, G, and I) were presented at position 220 (H3 numbering) in HA during passage in embryonated eggs. The residue at position 220 is located close to the receptor-binding site and the biological characteristics of this site remain to be elucidated. Therefore, in this study, using reverse genetics, we constructed two viruses carrying the single substitution in position 220 of HA (HA-G and HA-I) and evaluated the biological effects of substitution (R with G/I) on receptor binding, neuraminidase (NA) activity, growth characteristics, genetic stability, and antigenicity. The results revealed both mutant viruses exhibited lower HA binding affinities to two receptor types (sialic acid in alpha2,3- and alpha2,6-linkage to galactose, P < 0.001) and significant better growth characteristics compared to HA-R in two cells. Moreover, under similar NA enzymatic activity, the two mutant viruses eluted more easily from agglutinated erythrocytes than HA-R. Collectively, these results implied the balance of HA and NA in mutant viruses was a stronger determinant of viral growth than the individual amino acid in the HA position 220 in HA-R without strong binding between HA and sialylated receptors. Importantly, both the substitutions conferred altered antigenicity to the mutant viruses. In conclusion, amino acid substitutions at position 220 can substantially influence viral biological properties.

Entities:  

Keywords:  Antigenicity; Avian influenza H7N9 virus; Growth characteristic; Hemagglutinin; Receptor affinity; Substitution

Year:  2021        PMID: 33606171     DOI: 10.1007/s11262-021-01827-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  11 in total

Review 1.  A Systematic Review of the Comparative Epidemiology of Avian and Human Influenza A H5N1 and H7N9 - Lessons and Unanswered Questions.

Authors:  C Bui; A Bethmont; A A Chughtai; L Gardner; S Sarkar; S Hassan; H Seale; C R MacIntyre
Journal:  Transbound Emerg Dis       Date:  2015-01-29       Impact factor: 5.005

2.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

3.  Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site.

Authors:  Hua Yang; Li-Mei Chen; Paul J Carney; Ruben O Donis; James Stevens
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

4.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

5.  Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.

Authors:  Wenfei Zhu; Jianfang Zhou; Zi Li; Lei Yang; Xiyan Li; Weijuan Huang; Sumei Zou; Wenbing Chen; Hejiang Wei; Jing Tang; Liqi Liu; Jie Dong; Dayan Wang; Yuelong Shu
Journal:  Euro Surveill       Date:  2017-05-11

6.  Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.

Authors:  Donald J Benton; Stephen A Wharton; Stephen R Martin; John W McCauley
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

7.  A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.

Authors:  Xing Li; Yamei Gao; Zhiping Ye
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

8.  Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study.

Authors:  Li Li; Yunning Liu; Peng Wu; Zhibin Peng; Xiling Wang; Tao Chen; Jessica Y T Wong; Juan Yang; Helen S Bond; Lijun Wang; Yiu Chung Lau; Jiandong Zheng; Shuo Feng; Ying Qin; Vicky J Fang; Hui Jiang; Eric H Y Lau; Shiwei Liu; Jinlei Qi; Juanjuan Zhang; Jing Yang; Yangni He; Maigeng Zhou; Benjamin J Cowling; Luzhao Feng; Hongjie Yu
Journal:  Lancet Public Health       Date:  2019-09

9.  Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Suzana Sabaiduc; Alireza Eshaghi; James A Dickinson; Kevin Fonseca; Anne-Luise Winter; Jonathan B Gubbay; Mel Krajden; Martin Petric; Hugues Charest; Nathalie Bastien; Trijntje L Kwindt; Salaheddin M Mahmud; Paul Van Caeseele; Yan Li
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.

Authors:  Nicholas C Wu; Seth J Zost; Andrew J Thompson; David Oyen; Corwin M Nycholat; Ryan McBride; James C Paulson; Scott E Hensley; Ian A Wilson
Journal:  PLoS Pathog       Date:  2017-10-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.